Gene editing is described as a way to precisely model pathogenic variants and correct disease-associated mutations in pluripotent stem cell-derived hepatic cells.
First-pass extracted concept
gene editing
Extracted Explainers
What the tool is doing
The review presents gene editing as an emerging alternative strategy for sustainable parasite control in aquaculture.
The abstract lists gene editing as a highlighted technology in neural regeneration.
Gene editing is described as one of the engineering strategies used to reduce key barriers in CAR T-cell therapy for T-ALL.
Resources required
What problem it solves
It addresses the need for human-relevant liver disease models and targeted genetic correction in regenerative hepatic systems.
It is positioned as a way to move beyond traditional chemical treatments that face drug resistance and environmental toxicity problems.
It is presented as part of the recent breakthroughs promoting development of the field.
In the abstract, it is linked to mitigation of fratricide and product contamination risks.
What it does not solve
Evidence Snippets
The utility of these regenerative cell technologies is further expanded when combined with gene-editing techniques, which enable precise modeling of pathogenic variants and targeted correction of disease-associated mutations.
Emerging methods such as natural products, gene editing, immunotherapy, and auxiliary technologies like nanotechnology and biosensors are becoming alternative strategies for sustainable parasite control.
This review highlights the latest cutting-edge technologies driving progress in the field, including ... gene editing...
Gene editing, protein expression blockers, and antigen selection strategies have been employed to mitigate these risks
This review aims to summarize tissue- and developmental stage-specific expression patterns and highlight experimental approaches to validate RNA function, including gene editing, transcript recovery, advanced sequencing, and analysis of protein-RNA interactions.
Supporting Sources
Linked Claims
Gene editing can be used to enhance the functionality and therapeutic potential of regenerative hepatocyte products.
Gene editing enables precise modeling of pathogenic variants and targeted correction of disease-associated mutations in regenerative hepatic cell technologies.
These emerging parasite-control approaches have significant potential to prevent drug resistance and reduce environmental impact.
These methods show significant potential, particularly in preventing drug resistance and reducing environmental impact.
Natural products, gene editing, immunotherapy, nanotechnology, and biosensors are emerging as alternative strategies for sustainable parasite control in aquaculture.
Emerging methods such as natural products, gene editing, immunotherapy, and auxiliary technologies like nanotechnology and biosensors are becoming alternative strategies for sustainable parasite control.
Emerging approaches for sustainable parasite control in aquaculture remain at an early research stage and are hindered by unstable efficacy, limited field validation, and uncertain long-term safety.
However, these approaches remain at an early research stage, with issues such as unstable efficacy, limited validation in field conditions and uncertain long-term safety hindering their translation into practice.
Gene editing, protein expression blockers, and antigen selection strategies have been used to mitigate T-ALL CAR T-cell risks.
Gene editing, protein expression blockers, and antigen selection strategies have been employed to mitigate these risks
Traditional chemical treatments for parasite control in aquaculture face drug resistance as well as environmental pollution and toxicity challenges.
Parasite control in aquaculture faces challenges primarily due to the drug resistance of traditional chemical treatments, as well as environmental pollution and toxicity.
The review highlights optogenetics, chemogenetics, 3D culture models, gene editing, single-cell sequencing, and 3D imaging as cutting-edge technologies driving progress in neural regeneration.
This review highlights the latest cutting-edge technologies driving progress in the field, including optogenetics, chemogenetics, three-dimensional (3D) culture models, gene editing, single-cell sequencing, and 3D imaging.
The convergence of multidisciplinary approaches in neural regeneration is presented as having potential to enable more precise, efficient, and personalized therapeutic strategies and improve functional recovery.
The convergence of these multidisciplinary approaches holds immense potential for developing transformative treatments for neural injuries and neurological disorders, ultimately improving functional recovery.